Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia
NCT05992077
·
clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
21000
Enrollment
OTHER_GOV
Sponsor class
Conditions
HCV Infection
Interventions
DRUG:
Sofosbuvir/Daclatasvir
Sponsor
ANRS, Emerging Infectious Diseases
Collaborators
[object Object]